Caribou Biosciences (CRBU) Treasury Shares (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Treasury Shares data on file, last reported at $3.0 million in Q1 2026.

• Quarterly Treasury Shares rose 36.16% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 36.16% YoY) and the FY2025 annual result came in at $2.2 million, up 67.52% from the prior year.
• Treasury Shares advanced to $3.0 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.0 million in Q1 2026 and bottomed at $60000.0 in Q1 2022.
• The 5-year median for Treasury Shares is $1.2 million (2024), against an average of $1.1 million.
• The widest annual swing landed in 2023, when Treasury Shares plunged 35.16%; it then soared 673.49% in 2024.
• Tracing CRBU's Treasury Shares over 5 years: stood at $256146.0 in 2022, then fell by 19.83% to $205357.0 in 2023, then jumped by 531.74% to $1.3 million in 2024, then soared by 67.52% to $2.2 million in 2025, then soared by 38.95% to $3.0 million in 2026.
• Per Business Quant, the three latest CRBU Treasury Shares figures stand at $3.0 million (Q1 2026), $2.2 million (Q4 2025), and $2.2 million (Q3 2025).

Peer Comparison